Copaxone

Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition
RAPS.org
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
FDA
biologics
Flag link:
Teva forks over $54M to settle Copaxone, Azilect kickbacks suit
Teva forks over $54M to settle Copaxone, Azilect kickbacks suit
Fierce Pharma
Teva Pharmaceutgical
Copaxone
Azilect
kickbacks
whistleblower lawsuit
Flag link:
Teva shares approach 20-year low amid Moody’s warning and other woes
Teva shares approach 20-year low amid Moody’s warning and other woes
Fierce Pharma
Teva Pharmaceutical
Copaxone
opioids
Flag link:
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Fierce Pharma
FDA
Dr Reddy's
Copaxone
Teva Pharmaceutical
generics
Merck
Nuvaring
Flag link:
Teva predicts bleak year ahead as generic, Copaxone sales drop
Teva predicts bleak year ahead as generic, Copaxone sales drop
Biopharma Dive
Teva Pharmaceutical
Copaxone
Flag link:
Mylan's generic Copaxone wins in court, but market barriers remain
Mylan's generic Copaxone wins in court, but market barriers remain
Biopharma Dive
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
Flag link:
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
Motley Fool
Momenta Pharmaceuticals
Teva Pharmaceuticals
Copaxone
Novartis
biosimilars
Glatopa
Flag link:
Gilenya beats Copaxone head-to-head at higher dose, study finds
Gilenya beats Copaxone head-to-head at higher dose, study finds
Biopharma Dive
Novartis
Teva Pharmaceutical
MS
Copaxone
Gilenya
Flag link:
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Fierce Pharma
Teva Pharmaceutical
Copaxone
Azilect
kickbacks
generics
whistleblowers
Flag link:
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
Teva stock drops 4.5% in spite of Q2 profit beat, revenue match
Marketwatch
Teva Pharmaceutical
earnings
Copaxone
Flag link:
A Look at Teva’s Earnings Estimates ahead of Q2 Results
A Look at Teva’s Earnings Estimates ahead of Q2 Results
Market Realist
Teva Pharmaceutical
earnings
Copaxone
Flag link:
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already
Fierce Pharma
Mylan Labs
Copaxone
generics
Teva Pharmaceuticals
MS
drug pricing
Flag link:
Mylan decimates the list price of its Copaxone copy. But why?
Mylan decimates the list price of its Copaxone copy. But why?
Fierce Pharma
Mylan
drug pricing
Copaxone
Flag link:
5 Best-Selling Orphan Drugs in the U.S.
5 Best-Selling Orphan Drugs in the U.S.
Motley Fool
orphan drugs
Celgene
Revlimid
Roche
Rituxan
Teva Pharmaceutical
Copaxone
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
Flag link:
FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant
FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant
Fierce Pharma
FDA
Pfizer
drug manufacturing
Copaxone
generics
Flag link:
Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff
Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff
Endpoints
Novartis
Momenta Pharmaceuticals
FDA
Copaxone
Teva Pharmaceutical
Glatopa
MS
multiple sclerosis
Flag link:
Will Teva Pharmaceutical's Pain Be Mylan's Gain?
Will Teva Pharmaceutical's Pain Be Mylan's Gain?
Motley Fool
Teva Pharmaceutical
Mylan Labs
Copaxone
generics
MS
multiple sclerosis
Flag link:
Teva's Turnarond: Is It Ever Or Never?
Teva's Turnarond: Is It Ever Or Never?
Forbes
Teva Pharmaceutical
Copaxone
migraines
fremanezumab
Flag link:
Pfizer's manufacturing fix clears path for Momenta's Copaxone generic
Pfizer's manufacturing fix clears path for Momenta's Copaxone generic
Biopharma Dive
Pfizer
drug manufacturing
generics
Momenta Pharmaceuticals
Copaxone
Novartis
Flag link:
Look out, Teva: Mylan's Copaxone copy has already captured serious share
Look out, Teva: Mylan's Copaxone copy has already captured serious share
Fierce Pharma
Teva Pharmaceutical
Mylan Labs
Copaxone
generics
MS
multiple sclerosis
Flag link:

Pages